Here is a link to another example of Government making the wrong decision, leading to delayed availability of a drug that is effective for MS.
Government regulators run the risk of criticism (or worse) if they release a drug that turns out to have adverse effects, even if there is reasonable evidence that it will help. On the other hand, if they do not release the drug, it is unlikely that they will be criticized. The result is a tendency for potentially life improving drugs not to reach the market or to be substantially delayed.
No comments:
Post a Comment